Medical Lead with 24 years of working experience in various positions across the human drug development process within CRO and Pharma.
Passionate for the science of Oncology, Hematology, Immunology, and Pharmaceutical Medicine.
Innovator and early adopter of contemporary methods in drug development practice.
CRO Medical Lead overseeing the development program of 3 ADC assets (program consisted of 21 trials)
Syneos Medical Oncology Group Leader, working closely with a network of SMEs (Biostats, Data Sciences, CliniOps, and others) for clinical trials' efficiency increase (use of innovative trial designs, advanced data monitoring, solutions based on Machine Learning, Artificial Intelligence and Real World Data).
In recent roles, acted as CRO Clinical Development Lead for Biotech organizations, transitioning assets from pre-clinical to clinical setting (IND development, FIH and subsequent protocols writing).
Medical and clinical subject matter expert on strategic drug development projects
Strategic drug development